CLINICAL_TRIALS
trial_result
· 2024-05-14
Clinical Trial Update: Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2) [Phase 3]
Summary
Phase 3 trial (EPIONE2) evaluating tradipitant vs placebo for atopic dermatitis was terminated with results posted in May 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vanda Pharmaceuticals | Conditions: Atopic Dermatitis | Phase 3 | Status: TERMINATED | Results posted: 2024-05-14